US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Spdr S&P Biotech Etf

154.43

-0.0800-0.05%

Post-market: 154.21-0.2200-0.14%19:52 EDT

Volume:8.75M

Turnover:1.35B

Market Cap:10.16B

PE:8.47

High:156.74

Open:156.41

Low:153.58

Close:154.51

52wk High:169.89

52wk Low:101.01

Shares:65.80M

Float Shares:65.80M

Volume Ratio:1.04

T/O Rate:13.30%

Dividend:0.55

Dividend Rate:0.35%

EPS(TTM):18.23

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Press Release: Primrose Bio(R) Raises Significant Growth Capital Investment Led by Signet Healthcare Partners

Health Care Select Sector SPDR: Pivot points

Hot Stock Hits Four Straight Limit-Up Days, Company Issues Warning

Rooted in Zhangjiang, Connected to the World: SH Pharma Powers an Open Innovation Ecosystem as an Ecosystem Anchor

PDS Biotech Announces Publication of VERSATILE-002 Phase 2 Clinical Trial Results of PDS0101 with pembrolizumab in HPV16-Positive Recurrent and/or Metastatic (R/M) Head and Neck Cancer in JAMA Oncology

Analysts’ Opinions Are Mixed on These Healthcare Stocks: CVRx (CVRX), Butterfly Network (BFLY) and Viridian Therapeutics (VRDN)

Analysts’ Opinions Are Mixed on These Healthcare Stocks: AnaptysBio (ANAB), Alkermes (ALKS) and Iradimed (IRMD)

Buy Rating Reiterated on Foralumab Data Catalysts, $7 Price Target Maintained

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Invivyd (IVVD) and Humacyte (HUMA)

EPF Raises Stake in IHH Healthcare to 13.2%

H.C. Wainwright Sticks to Their Buy Rating for Moleculin Biotech (MBRX)

Man Group PLC : Form 8.3 - Spire Healthcare Group Plc

H.C. Wainwright Sticks to Its Buy Rating for Evaxion Biotech (EVAX)

Observe Medical Launches New Website to Deepen Dialogue With Healthcare Decision-Makers

Analysts Are Bullish on These Healthcare Stocks: Ligand Pharma (LGND), Disc Medicine (IRON)

Health Care Roundup: Market Talk

Analysts Offer Insights on Healthcare Companies: Abivax SA Sponsored ADR (ABVX) and Siemens Healthineers AG (OtherSEMHF)

China Accepts Anke Biotech's Clinical Trial Application for Tumor Drug

MT Newswires Live

Kolmar Biotech Finalizes Low-Risk Merger of Wholly Owned Unit MOD Materials

Health Care up on Drug Breakthrough Hopes - Health Care Roundup

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/XBI/news?page=15"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"XBI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","market":"US","secType":"STK","nameCN":"Spdr S&P Biotech Etf","latestPrice":154.43,"timestamp":1790971200000,"preClose":154.51,"halted":0,"volume":8753286,"hourTrading":{"tag":"盘后","latestPrice":154.21,"preClose":154.43,"latestTime":"19:52 EDT","volume":569175,"amount":87915169.8226,"timestamp":1790985149312,"change":-0.22,"changeRate":-0.001425,"amplitude":0.003821},"delay":0,"changeRate":-0.0005177658403985767,"floatShares":65800000,"shares":65800000,"eps":18.23,"marketStatus":"Market Closed","change":-0.08,"latestTime":"10-02 16:00:00 EDT","open":156.41,"high":156.74,"low":153.575,"amount":1354998518.98824,"amplitude":0.020484,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":18.23,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":154.51,"sharesOutstanding":63325000,"nav":154.512981,"aum":10101286126.545,"dividendRate":0.003549,"bidAskSpread":0.000319,"preHourTrading":{"tag":"盘前","latestPrice":156.2108,"preClose":154.51,"latestTime":"09:28 EDT","volume":24787,"amount":3885699.3532,"timestamp":1790947734577,"change":1.7008,"changeRate":0.011008,"amplitude":0.015404},"postHourTrading":{"tag":"盘后","latestPrice":154.21,"preClose":154.43,"latestTime":"19:52 EDT","volume":569175,"amount":87915169.8226,"timestamp":1790985149312,"change":-0.22,"changeRate":-0.001425,"amplitude":0.003821},"volumeRatio":1.036833,"impliedVol":0.3149,"impliedVolPercentile":0.5259},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","floatShares":65800000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.036833,"shares":65800000,"dividePrice":0.5481,"high":156.74,"amplitude":0.020484,"preClose":154.51,"low":153.575,"week52Low":101.01,"pbRate":"--","week52High":169.89,"institutionHeld":0.8511,"latestPrice":154.43,"eps":18.23,"divideRate":0.003549,"volume":8753286,"delay":0,"ttmEps":18.23,"open":156.41,"prevYearClose":121.93,"prevWeekClose":155.03,"prevMonthClose":157.68,"prevQuarterClose":157.68,"fiveDayClose":155.03,"twentyDayClose":164.38,"sixtyDayClose":164.28},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XBI\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"XBI","amount":0.138094,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-24","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-24"},{"date":"2025-12-22","symbol":"XBI","amount":0.406564,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-24"},{"date":"2025-09-22","symbol":"XBI","amount":0.02665,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-24","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-24"},{"date":"2025-06-23","symbol":"XBI","amount":0.007295,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-25","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-25"},{"date":"2025-03-24","symbol":"XBI","amount":0.00525,"announcedDate":"2025-03-21","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-24","defaultRemindTime":1742823000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-26","payableDate":"2025-03-24","currency":"USD","dateTimestamp":1742788800000,"payDate":"2025-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XBI\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-27","value":0.01831,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-27","value":0.019702,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-26","value":0.110135,"currency":"USD"},{"executeDate":"2017-09-15","recordDate":"2017-09-18","paymentDate":"2017-09-25","value":0.03704,"currency":"USD"},{"executeDate":"2018-03-16","recordDate":"2018-03-19","paymentDate":"2018-03-21","value":0.059081,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XBI\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XBI\",pageSize:20,pageCount:15,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2669421791","title":"Press Release: Primrose Bio(R) Raises Significant Growth Capital Investment Led by Signet Healthcare Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2669421791","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669421791?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:00","pubTimestamp":1790082000,"startTime":"0","endTime":"0","summary":"SAN DIEGO, Sept. 22, 2026 /PRNewswire/ -- Primrose Bio, Inc. , a provider of production solutions for next-generation biologics, today announced the closing of a financing round led by new investor Signet Healthcare Partners , with significant participation from existing investors 1315 Capital, Ligand Pharmaceuticals Incorporated , LDV Partners, and Agent Capital. In conjunction with the financing, James Gale, Founding Partner and Managing Director of Signet, has joined Primrose's Board of Directors.The proceeds will help Primrose continue to expand the reach and capabilities of its differentiated technology portfolio:-- Pfenex Expression Technology , a scalable microbial. expression platform for efficient, high-yield production of complex,-- Prima RNApols, proprietary RNA polymerases for consistent, scalable,-- PeliCRM197, a validated carrier protein used in multiple approved","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","R","LU0128526141.USD","LABU","BK4139","LU0566484027.USD","BK4581","HELX","IE0009354923.USD","BK4007","LU1559883803.SGD","BK4022","XLV","LGND","BK4137","LU0029874061.USD","XBI","BK4588","HCSG","BK4232"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669797144","title":"Health Care Select Sector SPDR: Pivot points","url":"https://stock-news.laohu8.com/highlight/detail?id=2669797144","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669797144?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:25","pubTimestamp":1790079948,"startTime":"0","endTime":"0","summary":"The following are the pivot points for the Health Care Select Sector SPDR (XLV). Pivot High: $170.61, Pivot Low: $167.93. These were calculated usi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/health-care-select-sector-spdr-pivot-points-thefly-news-147?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/health-care-select-sector-spdr-pivot-points-thefly-news-147?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","BK4585","BK4588","LABU","XBI","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189724351","title":"Hot Stock Hits Four Straight Limit-Up Days, Company Issues Warning","url":"https://stock-news.laohu8.com/highlight/detail?id=1189724351","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189724351?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:20","pubTimestamp":1790079626,"startTime":"0","endTime":"0","summary":"Nanhua Bio-medicine Co., Ltd. (SZ: 000504, share price 12.11 yuan, market cap 3.997 billion yuan) released a stock trading risk warning announcement on the evening of September 22. The company's...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TTM","BK4585","BK4099","XBI","BK4588","BK4523","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188405835","title":"Rooted in Zhangjiang, Connected to the World: SH Pharma Powers an Open Innovation Ecosystem as an Ecosystem Anchor","url":"https://stock-news.laohu8.com/highlight/detail?id=1188405835","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188405835?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:01","pubTimestamp":1790078471,"startTime":"0","endTime":"0","summary":"As 2026 marks the opening year of China's 15th Five-Year Plan, the Government Work Report from the Two Sessions has, for the first time, designated biomedicine as an emerging pillar industry, calling...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","BK0183","BK0184","BK0209","BK0099","BK0175","399441","BK0097","BK0020","BK0188","BK4581","601607","161726","BK0196","02607","BK4585","BK4588","BK0028","BK1197","BK0187","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669882142","title":"PDS Biotech Announces Publication of VERSATILE-002 Phase 2 Clinical Trial Results of PDS0101 with pembrolizumab in HPV16-Positive Recurrent and/or Metastatic (R/M) Head and Neck Cancer in JAMA Oncology","url":"https://stock-news.laohu8.com/highlight/detail?id=2669882142","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669882142?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:00","pubTimestamp":1790078400,"startTime":"0","endTime":"0","summary":"39.3 months median overall survival in first-line (1L) R/M immune checkpoint inhibitor nave patients Company continues to prioritize PDS0301 in metastatic colorectal cancer (mCRC) while pursuing partn","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/22/3366230/37149/en/pds-biotech-announces-publication-of-versatile-002-phase-2-clinical-trial-results-of-pds0101-with-pembrolizumab-in-hpv16-positive-recurrent-and-or-metastatic-r-m-head-and-neck-canc.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","IDNA","XBI","BK4588","ORR","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669149323","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: CVRx (CVRX), Butterfly Network (BFLY) and Viridian Therapeutics (VRDN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669149323","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669149323?lang=en_us&edition=fundamental","pubTime":"2026-09-22 19:10","pubTimestamp":1790075417,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on CVRx (CVRX), Butterfly Network (BFLY) and Viridian Therapeutics (...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-cvrx-cvrx-butterfly-network-bfly-and-viridian-therapeutics-vrdn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-cvrx-cvrx-butterfly-network-bfly-and-viridian-therapeutics-vrdn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LABU","BK4139","XBI","CVRX","XLV","HCSG","VRDN","BK4585","BK4082","BK4581","LU0128526141.USD","BFLY","BK4539","BK4137","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669678146","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: AnaptysBio (ANAB), Alkermes (ALKS) and Iradimed (IRMD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669678146","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669678146?lang=en_us&edition=fundamental","pubTime":"2026-09-22 18:50","pubTimestamp":1790074221,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on AnaptysBio (ANAB), Alkermes (ALKS) and Iradimed (IRMD). AnaptysBi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-anaptysbio-anab-alkermes-alks-and-iradimed-irmd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-anaptysbio-anab-alkermes-alks-and-iradimed-irmd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL","ALKS","BK4137","XLV","PSCH","BK4588","LABU","XBI","LU0029874061.USD","MEDX","FFTY","IRMD","BK4139","FBT","LU0128526141.USD","BK4581","BK4082","BK4585","HCSG","IBRN","ANAB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669143053","title":"Buy Rating Reiterated on Foralumab Data Catalysts, $7 Price Target Maintained","url":"https://stock-news.laohu8.com/highlight/detail?id=2669143053","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669143053?lang=en_us&edition=fundamental","pubTime":"2026-09-22 18:15","pubTimestamp":1790072132,"startTime":"0","endTime":"0","summary":"Tiziana Life Sciences, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Thomas Shrader from BTIG maintained...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-reiterated-on-foralumab-data-catalysts-7-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-reiterated-on-foralumab-data-catalysts-7-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","XLV","BK4585","XBI","BK4588","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669143096","title":"Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Invivyd (IVVD) and Humacyte (HUMA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669143096","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669143096?lang=en_us&edition=fundamental","pubTime":"2026-09-22 18:10","pubTimestamp":1790071809,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Amgen (AMGN), Invivyd (IVVD) and Humacyte (HUMA). ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amgen-amgn-invivyd-ivvd-and-humacyte-huma-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amgen-amgn-invivyd-ivvd-and-humacyte-huma-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0889565916.HKD","PJP","BBH","XBI","BIB","BK4534","LU2468319806.SGD","XLV","LU1571399168.USD","LU0029874061.USD","LU2089984988.USD","IE00BJJMRZ35.SGD","BK4599","HCSG","BK4588","LU0320765992.SGD","BK4585","IE0002141913.USD","LU0109394709.USD","LU2242646821.SGD","LU0868494617.USD","IE0009355771.USD","BK4137","LU1023059063.AUD","AMGN","IE00B4R5TH58.HKD","IE00B2B36J28.USD","LU1057294990.SGD","BK4539","LU0058720904.USD","LU0122379950.USD","LU1061106388.HKD","LU1983299246.USD","LABU","BK4533","LU0289739699.SGD","IBBQ","IVVD","PBE","LU0128526141.USD","BK4139","BK4566","LU2242652126.USD","HUMA","BK4563","SG9999001440.SGD","TBXU","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669143323","title":"EPF Raises Stake in IHH Healthcare to 13.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669143323","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669143323?lang=en_us&edition=fundamental","pubTime":"2026-09-22 17:47","pubTimestamp":1790070467,"startTime":"0","endTime":"0","summary":"An update from IHH Healthcare Bhd ( ($IHHHF) ) is now available. Malaysia’s Employees Provident Fund Board (EPF), a substantial shareholder in IHH ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/epf-raises-stake-in-ihh-healthcare-to-13-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/epf-raises-stake-in-ihh-healthcare-to-13-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","BK4585","BK4581","HCSG","XLV","LU0128526141.USD","LU0029874061.USD","LABU","BK4588","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669824143","title":"H.C. Wainwright Sticks to Their Buy Rating for Moleculin Biotech (MBRX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669824143","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669824143?lang=en_us&edition=fundamental","pubTime":"2026-09-22 17:45","pubTimestamp":1790070352,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Sara Nik from H.C. Wainwright maintained a Buy rating on Moleculin Biotech, with a price target of $3.00. The compa...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-sticks-to-their-buy-rating-for-moleculin-biotech-mbrx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-sticks-to-their-buy-rating-for-moleculin-biotech-mbrx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MBRX","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669148753","title":"Man Group PLC : Form 8.3 - Spire Healthcare Group Plc","url":"https://stock-news.laohu8.com/highlight/detail?id=2669148753","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669148753?lang=en_us&edition=fundamental","pubTime":"2026-09-22 17:41","pubTimestamp":1790070060,"startTime":"0","endTime":"0","summary":"FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.KEY INFORMATION (a)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/22/3366081/0/en/man-group-plc-form-8-3-spire-healthcare-group-plc.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","LU0029874061.USD","BK4588","LABU","XLV","BK4585","BK4581","HCSG","BK4137","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669148654","title":"H.C. Wainwright Sticks to Its Buy Rating for Evaxion Biotech (EVAX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669148654","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669148654?lang=en_us&edition=fundamental","pubTime":"2026-09-22 17:35","pubTimestamp":1790069717,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Swayampakula Ramakanth from H.C. Wainwright reiterated a Buy rating on Evaxion Biotech, with a price target of $16....","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-sticks-to-its-buy-rating-for-evaxion-biotech-evax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-sticks-to-its-buy-rating-for-evaxion-biotech-evax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","EVAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669148572","title":"Observe Medical Launches New Website to Deepen Dialogue With Healthcare Decision-Makers","url":"https://stock-news.laohu8.com/highlight/detail?id=2669148572","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669148572?lang=en_us&edition=fundamental","pubTime":"2026-09-22 17:32","pubTimestamp":1790069557,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Observe Medical ASA ( ($DE:OM50) ). Observe Medical ASA has launched a new website aimed at strengthening direc...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/observe-medical-launches-new-website-to-deepen-dialogue-with-healthcare-decision-makers?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/observe-medical-launches-new-website-to-deepen-dialogue-with-healthcare-decision-makers?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","BK4585","BK4581","HCSG","XLV","LU0128526141.USD","LU0029874061.USD","LABU","BK4588","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669148615","title":"Analysts Are Bullish on These Healthcare Stocks: Ligand Pharma (LGND), Disc Medicine (IRON)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669148615","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669148615?lang=en_us&edition=fundamental","pubTime":"2026-09-22 17:30","pubTimestamp":1790069407,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Ligand Pharma (LGND), Disc Medicine (IRON) and Immun...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-ligand-pharma-lgnd-disc-medicine-iron-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-ligand-pharma-lgnd-disc-medicine-iron-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","LU0053671581.USD","IRON","LGND","HELX","LU1559883803.SGD","BK4588","BK4137","BK4007","BK4585","BK4139","XLV","LABU","LU0566484027.USD","XBI","BK4581","HCSG","IE0009354923.USD","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669217112","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2669217112","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669217112?lang=en_us&edition=fundamental","pubTime":"2026-09-22 16:20","pubTimestamp":1790065200,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0743 GMT - EssilorLuxottica is expected to benefit from more dur","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","BK4585","BK4588","LABU","XBI","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669125551","title":"Analysts Offer Insights on Healthcare Companies: Abivax SA Sponsored ADR (ABVX) and Siemens Healthineers AG (OtherSEMHF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669125551","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669125551?lang=en_us&edition=fundamental","pubTime":"2026-09-22 15:40","pubTimestamp":1790062807,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Abivax SA Sponsored ADR (ABVX) and Siemens Healthine...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-abivax-sa-sponsored-adr-abvx-and-siemens-healthineers-ag-othersemhf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-abivax-sa-sponsored-adr-abvx-and-siemens-healthineers-ag-othersemhf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARMH","ABVX","CVY","LU0128526141.USD","LU0029874061.USD","BK4585","DINT","HCSG","AAVXF","XBI","BK4139","SAPH","AADR","BK4137","APIE","XLV","BK4588","LABU","BK4581","DIVL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669311914","title":"China Accepts Anke Biotech's Clinical Trial Application for Tumor Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2669311914","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669311914?lang=en_us&edition=fundamental","pubTime":"2026-09-22 14:45","pubTimestamp":1790059546,"startTime":"0","endTime":"0","summary":"Anhui Anke Biotechnology   has won approval from China's National Medical Products Administration  to carry out clinical trials for its AK2405 drug for injection, according to a Monday filing with the Shenzhen bourse.The injection is a HER2-targeting antibody-drug conjugate , which has an antibody component that specifically binds to the target antigen on the surface of tumor cells.The product is classified under Registration Category 1 for therapeutic biological products and is used to treat advanced malignant solid tumors.The company said preclinical studies showed high specificity and anti-tumor activity.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ADC.AU","300009","BK4581","BK0042","BK4588","BK0060","ADC","BK7095","NETL","BK4080","BK0070","BK0239","BK4585","XBI","BK4231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669192951","title":"Kolmar Biotech Finalizes Low-Risk Merger of Wholly Owned Unit MOD Materials","url":"https://stock-news.laohu8.com/highlight/detail?id=2669192951","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669192951?lang=en_us&edition=fundamental","pubTime":"2026-09-22 09:14","pubTimestamp":1790039644,"startTime":"0","endTime":"0","summary":"WOOJUNG BIO, Inc. ( ($KR:215380) ) has issued an update. Kolmar Biotech Co., Ltd., a biotechnology and advanced materials company based in Hwaseong...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kolmar-biotech-finalizes-low-risk-merger-of-wholly-owned-unit-mod-materials?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kolmar-biotech-finalizes-low-risk-merger-of-wholly-owned-unit-mod-materials?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4544","BBP","SYNB","IBB","BK4588","FWD","BK4585","UYM","LNGR","BK4581","ARKG","XBI","TYNE","AGNG","RSPH","IEIH","JDOC","DARP","TINT","FHLC","XT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669193492","title":"Health Care up on Drug Breakthrough Hopes - Health Care Roundup","url":"https://stock-news.laohu8.com/highlight/detail?id=2669193492","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669193492?lang=en_us&edition=fundamental","pubTime":"2026-09-22 05:03","pubTimestamp":1790024580,"startTime":"0","endTime":"0","summary":"Health-care companies rose amid hopes for new drug breakthroughs.Shares of Moderna surged by more than 10%, and the vaccine maker has now risen more than fivefold for the year to date, after abstracts","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","BK4585","LABU","BK4588","XBI","XLV"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":17,"pageCount":15,"totalSize":337,"code":"91000000","status":"200"}]}}